IP Library › Granted Patent US 12,714,834
Granted Patent B2
US 12,714,834 · App. 18/644,498 · Granted Aug 25, 2026

Chemical ablation and method of treatment for various diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,714,834
App. No.
18/644,498
Filed
Apr 24, 2024
Granted
Aug 25, 2026
Kind
B2
Art Unit
3783
USPC
604/24
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2024
From: WANG, LIXIAO; CHEN, JOHN J.; ZHANG, YONGXING
To: NEUROTRONIC, INC.
Reel/Frame 067211/0640 →
Continuity (7)
Continuation 16986717 · Aug 6, 2020
Continuation 16563213 · Sep 6, 2019
Continuation 16156163 · Oct 10, 2018
Continuation 15521973 · Oct 30, 2015
Provisional Application 62124868 · Jan 5, 2015
Provisional Application 62122818 · Oct 30, 2014
Related Publication 20240277976A1 · Aug 22, 2024
References Cited (400)
US 4254056A · Konno et al. · 1981 [cited by applicant]
US 4573966A · Weikl et al. · 1986 [cited by applicant]
US 4653438A · Russell · 1987 [cited by applicant]
US 4684363A · Ari · 1987 [cited by examiner]
US 5045061A · Seifert et al. · 1991 [cited by applicant]
US 5263931A · Miller · 1993 [cited by applicant]
US 5314443A · Rudnick · 1994 [cited by applicant]
US 5315992A · Dalton · 1994 [cited by applicant]
US 5380284A · Don · 1995 [cited by applicant]
US 5419763A · Hildebrand · 1995 [cited by applicant]
US 5423755A · Kesten et al. · 1995 [cited by applicant]
US 5460610A · Don · 1995 [cited by applicant]
US 5599307A · Bacher et al. · 1997 [cited by applicant]
US 5681281A · Vigil et al. · 1997 [cited by applicant]
US 5720735A · Dorros · 1998 [cited by applicant]
US 6048332A · Duffy et al. · 2000 [cited by applicant]
US 6062223A · Palazzo et al. · 2000 [cited by applicant]
US 6135981A · Dyke · 2000 [cited by applicant]
US 6148222A · Ramsey, III · 2000 [cited by applicant]
US 6217554B1 · Green · 2001 [cited by applicant]
US 6258087B1 · Edwards et al. · 2001 [cited by applicant]
US 6444233B1 · Arntzen et al. · 2002 [cited by applicant]
US 6623452B2 · Chien et al. · 2003 [cited by applicant]
US 6685672B1 · Forman · 2004 [cited by applicant]
US 7617005B2 · Demarais et al. · 2009 [cited by applicant]
US 7653438B2 · Deem et al. · 2010 [cited by applicant]
US 7717948B2 · Demarais et al. · 2010 [cited by applicant]
US 8052668B2 · Sih · 2011 [cited by applicant]
US 8128592B2 · Mitelberg · 2012 [cited by examiner]
US 8372054B2 · Duffy et al. · 2013 [cited by applicant]
US 8740849B1 · Fischell et al. · 2014 [cited by applicant]
US 8774913B2 · Demarais et al. · 2014 [cited by applicant]
US 8840601B2 · Salahieh et al. · 2014 [cited by applicant]
US 9114123B2 · Vafai et al. · 2015 [cited by applicant]
US 10286191B2 · Wang et al. · 2019 [cited by applicant]
US 10537375B2 · Wang · 2020 [cited by applicant]
US 10758713B2 · Wang et al. · 2020 [cited by applicant]
US 11382689B2 · Wang · 2022 [cited by applicant]
US 11517725B2 · Wang et al. · 2022 [cited by applicant]
US 11648378B2 · Wang et al. · 2023 [cited by applicant]
US 11684417B2 · Wang · 2023 [cited by applicant]
US 12005207B2 · Wang et al. · 2024 [cited by applicant]
US 12193731B2 · Wang · 2025 [cited by applicant]
US 12208224B2 · Wang et al. · 2025 [cited by applicant]
US 20020014238A1 · Kotmel · 2002 [cited by applicant]
US 20020068953A1 · Kokish · 2002 [cited by applicant]
US 20020177846A1 · Mulier · 2002 [cited by applicant]
US 20030066532A1 · Gobel · 2003 [cited by applicant]
US 20040064150A1 · Becker · 2004 [cited by applicant]
US 20040089313A1 · Utley et al. · 2004 [cited by applicant]
US 20040116852A1 · Scopton · 2004 [cited by applicant]
US 20040267336A1 · Morrison et al. · 2004 [cited by applicant]
US 20050288639A1 · Hibner · 2005 [cited by applicant]
US 20060161233A1 · Barry et al. · 2006 [cited by applicant]
US 20060235474A1 · Demarais · 2006 [cited by applicant]
US 20060265014A1 · Demarais et al. · 2006 [cited by applicant]
US 20060282120A1 · Sih · 2006 [cited by applicant]
US 20070077230A1 · Mon · 2007 [cited by applicant]
US 20080051721A1 · Carter et al. · 2008 [cited by applicant]
US 20080114297A1 · Barry et al. · 2008 [cited by applicant]
US 20080118544A1 · Wang · 2008 [cited by applicant]
US 20080208118A1 · Goldman · 2008 [cited by applicant]
US 20080255508A1 · Wang · 2008 [cited by applicant]
US 20080255509A1 · Wang · 2008 [cited by applicant]
US 20080275445A1 · Kelly · 2008 [cited by examiner]
US 20090192505A1 · Askew et al. · 2009 [cited by applicant]
US 20090301483A1 · Barry et al. · 2009 [cited by applicant]
US 20100010470A1 · Bates · 2010 [cited by applicant]
US 20100087781A1 · Adams et al. · 2010 [cited by applicant]
US 20100145304A1 · Cressman · 2010 [cited by applicant]
US 20100209472A1 · Wang · 2010 [cited by applicant]
US 20110093000A1 · Ogle et al. · 2011 [cited by applicant]
US 20110104061A1 · Seward · 2011 [cited by applicant]
US 20110152683A1 · Gerrans et al. · 2011 [cited by applicant]
US 20110182912A1 · Evans et al. · 2011 [cited by applicant]
US 20110218564A1 · Drasler et al. · 2011 [cited by applicant]
US 20120083809A1 · Drasler et al. · 2012 [cited by applicant]
US 20120116438A1 · Salahieh et al. · 2012 [cited by applicant]
US 20120197245A1 · Burnett et al. · 2012 [cited by applicant]
US 20120209251A1 · Bates · 2012 [cited by applicant]
US 20120215212A1 · Selzer et al. · 2012 [cited by applicant]
US 20120259269A1 · Meyer · 2012 [cited by applicant]
US 20120271277A1 · Fischell et al. · 2012 [cited by applicant]
US 20120271301A1 · Fischell et al. · 2012 [cited by applicant]
US 20130053792A1 · Fischell et al. · 2013 [cited by applicant]
US 20130138082A1 · Salahieh et al. · 2013 [cited by applicant]
US 20130178910A1 · Azamian · 2013 [cited by examiner]
US 20130189190A1 · Wang · 2013 [cited by applicant]
US 20130204068A1 · Gnanashanmugam et al. · 2013 [cited by applicant]
US 20130245665A1 · Scandurra et al. · 2013 [cited by applicant]
US 20140243872A1 · Cordray · 2014 [cited by applicant]
US 20140371736A1 · Levin et al. · 2014 [cited by applicant]
US 20150005805A1 · Kesten et al. · 2015 [cited by applicant]
US 20150056298A1 · Azamian et al. · 2015 [cited by applicant]
US 20150224289A1 · Seward · 2015 [cited by applicant]
US 20150272666A1 · Wang · 2015 [cited by applicant]
US 20150305943A1 · Hossainy et al. · 2015 [cited by applicant]
US 20160135879A1 · Beasley et al. · 2016 [cited by applicant]
US 20160310200A1 · Wang · 2016 [cited by applicant]
US 20170007310A1 · Rajagopalan et al. · 2017 [cited by applicant]
US 20180015264A1 · Wang et al. · 2018 [cited by applicant]
US 20180185618A1 · Sweeney · 2018 [cited by applicant]
US 20190015639A1 · Wang et al. · 2019 [cited by applicant]
US 20190038881A1 · Wang et al. · 2019 [cited by applicant]
US 20190076186A1 · Fischell et al. · 2019 [cited by applicant]
US 20190167918A1 · Fischell et al. · 2019 [cited by applicant]
US 20190307507A1 · Wang · 2019 [cited by applicant]
US 20190388147A1 · Wang · 2019 [cited by applicant]
US 20200009355A1 · Wang et al. · 2020 [cited by applicant]
US 20200016379A1 · Wang et al. · 2020 [cited by applicant]
US 20200086093A1 · Wang · 2020 [cited by applicant]
US 20200230373A1 · Stankus et al. · 2020 [cited by applicant]
US 20200360671A1 · Wang et al. · 2020 [cited by applicant]
US 20200398032A1 · Wang et al. · 2020 [cited by applicant]
US 20210275784A1 · Wang · 2021 [cited by applicant]
US 20210275785A1 · Wang · 2021 [cited by applicant]
US 20210275786A1 · Wang · 2021 [cited by applicant]
US 20210275787A1 · Wang · 2021 [cited by applicant]
US 20220233238A1 · Wang et al. · 2022 [cited by applicant]
US 20220233827A1 · Wang et al. · 2022 [cited by applicant]
US 20230075851A1 · Mayse et al. · 2023 [cited by applicant]
US 20230270489A1 · Wang · 2023 [cited by applicant]
US 20240277977A1 · Wang et al. · 2024 [cited by applicant]
US 20250025673A1 · Wang · 2025 [cited by applicant]
US 20250082400A1 · Wang · 2025 [cited by applicant]
US 20250352774A1 · Wang et al. · 2025 [cited by applicant]
CN 1593359A · 2005 [cited by applicant]
CN 101035593A · 2007 [cited by applicant]
CN 101861184A · 2010 [cited by applicant]
CN 102481428A · 2012 [cited by applicant]
CN 102573466A · 2012 [cited by applicant]
CN 102600546A · 2012 [cited by applicant]
CN 102698354A · 2012 [cited by applicant]
CN 102727986A · 2012 [cited by applicant]
CN 102743163A · 2012 [cited by applicant]
CN 107106820A · 2017 [cited by applicant]
CN 110772311A · 2020 [cited by applicant]
CN 113040895A · 2021 [cited by applicant]
CN 114025826A · 2022 [cited by applicant]
CN 118555975 · 2024 [cited by applicant]
EP 2497524A1 · 2012 [cited by applicant]
EP 2914326B1 · 2023 [cited by applicant]
EP 4230162 · 2024 [cited by applicant]
JP S5769814A · 1982 [cited by applicant]
JP H04215767A · 1992 [cited by applicant]
JP H07308382A · 1995 [cited by applicant]
JP 08508917A · 1996 [cited by applicant]
JP 2000279524A · 2000 [cited by applicant]
JP 2004035128A · 2004 [cited by applicant]
JP 2004180892A · 2004 [cited by applicant]
JP 2004528924A · 2004 [cited by applicant]
JP 2005506101A · 2005 [cited by applicant]
JP 2006502801A · 2006 [cited by applicant]
JP 2010078379A · 2010 [cited by applicant]
JP 2010519005A · 2010 [cited by applicant]
JP 2010528815A · 2010 [cited by applicant]
JP 2011519699A · 2011 [cited by applicant]
JP 2012505050A · 2012 [cited by applicant]
JP 2012508067A · 2012 [cited by applicant]
JP 2012517858A · 2012 [cited by applicant]
JP 2012524808A · 2012 [cited by applicant]
JP 2013517847A · 2013 [cited by applicant]
JP 2014524342A · 2014 [cited by applicant]
JP 2014527272A · 2014 [cited by applicant]
JP 2015536945A · 2015 [cited by applicant]
JP 2017533036A · 2017 [cited by applicant]
JP 6389185B2 · 2018 [cited by applicant]
JP 2018153239A · 2018 [cited by applicant]
JP 2020178075 · 2020 [cited by applicant]
JP 2020189858A · 2020 [cited by applicant]
JP 2021046397A · 2021 [cited by applicant]
JP 2022017822 · 2022 [cited by applicant]
JP 2022538239A · 2022 [cited by applicant]
JP 2023027052A · 2023 [cited by applicant]
JP 2024544038 · 2024 [cited by applicant]
JP 2024170628 · 2024 [cited by applicant]
JP 7622980 · 2025 [cited by applicant]
JP 2025111789 · 2025 [cited by applicant]
WO WO9421320A1 · 1994 [cited by applicant]
WO WO9618427A1 · 1996 [cited by applicant]
WO WO9717099A1 · 1997 [cited by applicant]
WO WO0119445A1 · 2001 [cited by applicant]
WO WO02051490A1 · 2002 [cited by applicant]
WO WO2006055695A1 · 2006 [cited by applicant]
WO WO2008106357A1 · 2008 [cited by applicant]
WO WO2009076732A1 · 2009 [cited by applicant]
WO WO2009082433A2 · 2009 [cited by applicant]
WO WO2010033686A1 · 2010 [cited by applicant]
WO WO2010124120A1 · 2010 [cited by applicant]
WO WO2011094367A1 · 2011 [cited by applicant]
WO WO2011119159A1 · 2011 [cited by applicant]
WO WO2013026565A1 · 2013 [cited by applicant]
WO WO2013028781A1 · 2013 [cited by applicant]
WO WO2013067382A1 · 2013 [cited by applicant]
WO WO2013090848A1 · 2013 [cited by applicant]
WO WO2014070820A2 · 2014 [cited by applicant]
WO WO2015058296A1 · 2015 [cited by applicant]
WO WO2016070032A1 · 2016 [cited by applicant]
WO WO2020264152A1 · 2020 [cited by applicant]
WO WO2023091475A1 · 2023 [cited by applicant]
De Jonge et al.—“Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes”—Obesity Surgery, 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23526068/ (Year: 2013). [cited by examiner]
Matthes et al.—“Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection”—Gastrointestinal Endoscopy, 2007. URL: https://www.sciencedirect.com/science/article/pii/S0016510706019195 (Year: 20… [cited by examiner]
“U.S. Appl. No. 17/719,032, Non Final Office Action mailed Sep. 24, 2025”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/709,120, Non Final Office Action mailed Oct. 24, 2025”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 19/281,082, Non Final Office Action mailed Nov. 5, 2025”, 15 pgs. [cited by applicant]
“Japanese Application Serial No. 2024-158261, Notification of Reasons for Refusal mailed Nov. 4, 2025”, W English Translation, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/719,032, Response filed Nov. 12, 2025 to Non Final Office Action mailed Sep. 24, 2025”, 8 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Response filed Nov. 11, 2025 to Communication Pursuant to Article 943 EPC mailed Jul. 14, 2025”, 119 pgs. [cited by applicant]
“European Application Serial No. 22826521.1, Communication Pursuant to Article 943 EPC mailed Nov. 26, 2025”, 5 pgs. [cited by applicant]
Chen, Shao-Liang, “Pulmonary artery denervation to treat pulmonary arterial hypertension the single-center, prospective, first-in-man PADN-1 study”, Journal of the American College of Cardiology 2013, doi 10.1016 j.jacc… [cited by applicant]
Lee, Hyeog Jong, “Chemical Ablation of the Gallbladder with Acetic Acid”, J Vase Interv Radiol, 2009, 6 pgs. [cited by applicant]
“U.S. Appl. No. 18/709,120, Response filed Dec. 17, 2025 to Non Final Office Action mailed Oct. 24, 2025” 15 pgs. [cited by applicant]
“U.S. Appl. No. 18/144,368, Notice of Allowance mailed Aug. 22, 2024”, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-178135, Response filed Sep. 3, 2024 to Notification of Reasons for Refusal mailed Jun. 4, 2024”, w English Claims, 15 pgs. [cited by applicant]
“Chinese Application Serial No. 202110227749.X, Response filed Sep. 10, 2024 to Office Action mailed Jul. 10, 2024”, w current English claims, 19 pgs. [cited by applicant]
“U.S. Appl. No. 18/295,961, Response filed Sep. 19, 2024 to Non Final Office Action mailed Jun. 21, 2024”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 18/295,961, Notice of Allowance mailed Oct. 1, 2024”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/010,271, Notice of Allowance mailed Oct. 1, 2024”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/010,271, Corrected Notice of Allowability mailed Oct. 9, 2024”, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202110227749.X, Office Action mailed Oct. 31, 2024”, w English translation, 11 pgs. [cited by applicant]
Chen, John, “Results of related clinical study described in Declaration”, Declaration under 37 C.F.R. section 1.132 filed in U.S. Appl. No. 16/986,717. This application is a continuation in part (CIP) of U.S. Appl. No. … [cited by applicant]
“Japanese Application Serial No. 2025-076723, Voluntary Amendment filed May 27, 2025”, w english claim, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/719,032, Restriction Requirement mailed Jun. 10, 2025”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/719,032, Response filed Jul. 16, 2025 to Restriction Requirement mailed Jun. 10, 2025”, 8 pgs. [cited by applicant]
“European Application Serial No. 24205384.1, Response filed Jul. 11, 2025 to Extended European Search Report mailed Dec. 12, 2024”, w claims, 13 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Communication Pursuant to Article 94(3) EPC mailed Jul. 14, 2025”, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202110227749.X, Response filed May 6, 2024 to Office Action mailed Dec. 22, 2023”, w current English claims, 15 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-169101, Examiners Decision of Final Refusal mailed May 14, 2024”, W English Translation, 4 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Notification of Reasons for Rejection mailed May 14, 2024”, W English Translation, 25 pgs. [cited by applicant]
“Recording of clinical analysis research association”, w English translation No. 5, [Online] Retrieved from the internet: http: www.jrsca.jp contents records contents PDF 5-PDF?, (Feb. 2005), 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/010,271, Restriction Requirement mailed May 22, 2024”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 050087, International Preliminary Report on Patentability mailed May 30, 2024”, 6 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-178135, Notification of Reasons for Refusal mailed Jun. 4, 2024”, w English translation, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/010,271, Response filed Jun. 12, 2024 to Restriction Requirement mailed May 22, 2024”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/295,961, Non Final Office Action mailed Jun. 21, 2024”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 18/144,368, Response filed Jul. 2, 2024 to Non Final Office Action mailed Apr. 12, 2024”, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202110227749.X, Office Action mailed Jul. 10, 2024”, w o English Translation, 4 pgs. [cited by applicant]
Sugimoto, Ayurni, “Nervous Control of Glucose Metabolism in the Liver”, W English translation Lifestyle Research vol. 3, No. 1, 138-141, (2001), 10 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Response filed Aug. 13, 2024 to Notification of Reasons for Rejection mailed May 14, 2024” w/English claims 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Advisory Action mailed Apr. 30, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Final Office Action mailed Feb. 25, 2019”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Final Office Action mailed May 9, 2018”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Non Final Office Action mailed Sep. 21, 2018”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Non Final Office Action mailed Oct. 20, 2017”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Preliminary Amendment filed Jul. 28, 2015”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Response filed Jan. 17, 2018 to Non Final Office Action mailed Oct. 20, 2017”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Response filed Apr. 16, 2019 to Final Office Action mailed Feb. 25, 2019”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Response filed Aug. 7, 2018 to Final Office Action mailed May 9, 2018”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Response filed Aug. 25, 2017 to Restriction Requirement mailed Jul. 14, 2017”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Response filed Oct. 8, 2018 to Non Final Office Action mailed Sep. 21, 2018”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 14/438,411, Restriction Requirement mailed Jul. 14, 2017”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Advisory Action mailed Jul. 30, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Corrected Notice of Allowability mailed Nov. 20, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Final Office Action mailed May 3, 2019”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Final Office Action mailed Aug. 16, 2018”, 26 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Non Final Office Action mailed Feb. 15, 2018”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Non Final Office Action mailed Nov. 30, 2018”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Notice of Allowance mailed Oct. 1, 2019”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Preliminary Amendment filed Apr. 20, 2016”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Response filed Mar. 20, 2019 to Non Final Office Action mailed Nov. 30, 2018”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Response filed Jun. 14, 2018 to Non Final Office Action mailed Feb. 15, 2018”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Response filed Jul. 1, 2019 to Final Office Action mailed May 3, 2019”, 20 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Response filed Oct. 26, 2018 to Final Office Action mailed Aug. 16, 2018”, 20 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Response filed Dec. 27, 2017 to Restriction Requirement mailed Oct. 31, 2017”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/133,976, Restriction Requirement mailed Oct. 31, 2017”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Examiner Interview Summary mailed Jun. 4, 2018”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Final Office Action mailed Jan. 15, 2019”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Non Final Office Action mailed May 18, 2018”, 21 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Non Final Office Action mailed Sep. 14, 2018”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Notice of Allowance mailed Mar. 27, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Preliminary Amendment filed Apr. 26, 2017”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Response filed Mar. 14, 2019 to Final Office Action mailed Jan. 15, 2019”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 15/521,973, Response filed Dec. 10, 2018 to Non Final Office Action mailed Sep. 14, 2018”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/156,163, Non Final Office Action mailed Apr. 2, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/156,163, Notice of Allowance mailed Jul. 22, 2020”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/156,163, Response filed Jul. 1, 2020 to Non Final Office Action mailed Apr. 2, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Corrected Notice of Allowability mailed Apr. 27, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Final Office Action mailed Feb. 24, 2022”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Non Final Office Action mailed Oct. 5, 2021”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Notice of Allowance mailed Apr. 11, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Preliminary Amendment filed Jul. 9, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Response filed Mar. 9, 2022 to Final Office Action mailed Feb. 24, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/419,587, Response filed Nov. 4, 2021 to Non Final Office Action mailed Oct. 5, 2021”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,192, Non Final Office Action mailed Nov. 30, 2022”, 21 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,192, Notice of Allowance mailed Mar. 8, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,192, Response filed Feb. 9, 2023 to Non Final Office Action mailed Nov. 30, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,213, Non Final Office Action mailed Sep. 15, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,213, Notice of Allowability mailed Mar. 1, 2023”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,213, Notice of Allowance mailed Feb. 3, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,213, Response filed Dec. 13, 2022 to Non Final Office Action mailed Sep. 15, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Non Final Office Action mailed May 12, 2022”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Non Final Office Action mailed Sep. 30, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Notice of Allowance mailed Feb. 11, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Notice of Allowance mailed Aug. 26, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Response filed Aug. 11, 2022 to Non Final Office Action mailed May 12, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/563,235, Response filed Nov. 16, 2021 to Non Final Office Action mailed Sep. 30, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Advisory Action mailed Jul. 26, 2023”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Final Office Action mailed May 15, 2023”, 26 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Final Office Action mailed Jul. 26, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Non Final Office Action mailed Feb. 6, 2023”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Non Final Office Action mailed Apr. 5, 2022”, 23 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Non Final Office Action mailed Aug. 24, 2023”, 23 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Response filed Apr. 18, 2023 to Non Final Office Action mailed Feb. 6, 2023”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Response filed Jul. 5, 2022 to Non Final Office Action mailed Apr. 5, 2022”, 19 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Response filed Jul. 13, 2023 to Final Office Action mailed May 15, 2023”, 19 pgs. [cited by applicant]
“U.S. Appl. No. 16/690,992, Response filed Oct. 26, 2022 to Final Office Action mailed Jul. 26, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Final Office Action mailed Nov. 1, 2023”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Non Final Office Action mailed May 31, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Notice of Allowance mailed Feb. 14, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Response filed Jan. 25, 2024 to Final Office Action mailed Nov. 1, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Response filed Apr. 19, 2023 to Restriction Requirement mailed Mar. 2, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Response filed Aug. 9, 2023 to Non Final Office Action mailed May 31, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/986,717, Restriction Requirement mailed Mar. 2, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/329,765, Restriction Requirement mailed Sep. 13, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/329,795, Restriction Requirement mailed Sep. 13, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/329,823, Restriction Requirement mailed Sep. 13, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/329,842, Restriction Requirement mailed Oct. 17, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 18/144,368, Non Final Office Action mailed Apr. 12, 2024”, 16 pgs. [cited by applicant]
“Chinese Application Serial No. 202080046425.X, Voluntary Amendment filed Jun. 14, 2022”, w/ English Claims, 12 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Office Action mailed Jan. 17, 2018”, (English Translation), 8 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Office Action mailed Feb. 19, 2019”, W/ English Translation, 6 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Office Action mailed May 19, 2017”, w/ English Translation, 18 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Office Action mailed Dec. 27, 2019”, w/ English translation, 12 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Response filed Apr. 2, 2018 to Office Action mailed Jan. 17, 2018”, w/ English claims, 15 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Response filed Aug. 23, 2019 to Office Action mailed Feb. 19, 2019”, w/English Claims, 14 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Response filed Oct. 9, 2017 to Office Action mailed May 19, 2017”, w/ English Claims, 16 pgs. [cited by applicant]
“Chinese Application Serial No. 201380055918.X, Response filed Nov. 27, 2008 to Office Action mailed”, w/English Claims, 16 pgs. [cited by applicant]
“Chinese Application Serial No. 201580058938.1, Office Action mailed Jul. 2, 2020”, w/ English translation, 14 pgs. [cited by applicant]
“Chinese Application Serial No. 201580058938.1, Office Action mailed Sep. 3, 2019”, W/English Translation, 17 pgs. [cited by applicant]
“Chinese Application Serial No. 201580058938.1, Response filed Mar. 18, 2020 to Office Action mailed Sep. 3, 2019”, w/English Claims, 15 pgs. [cited by applicant]
“Chinese Application Serial No. 201580058938.1, Response filed Nov. 24, 2020 to Office Action mailed Jul. 2, 2020”, w/English Claims, 16 pgs. [cited by applicant]
“Chinese Application Serial No. 201580058938.1, Voluntary Amendment mailed Feb. 22, 2018”, w/ English Claims, 21 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Decision of Rejection mailed Mar. 14, 2023”, w/ English translation, 13 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Office Action mailed May 20, 2022”, w/ English translation, 16 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Office Action mailed Oct. 18, 2022”, w/ English translation, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Response filed Feb. 27, 2023 to Office Action mailed Oct. 18, 2022”, w/ English Claims, 8 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Response filed Jun. 28, 2023 to Decision of Rejection mailed Mar. 14, 2023”, w/ English Claims, 13 pgs. [cited by applicant]
“Chinese Application Serial No. 201910917938.2, Response filed Sep. 28, 2022 to Office Action mailed May 20, 2022”, w/ English Claims, 7 pgs. [cited by applicant]
“Chinese Application Serial No. 202110227749.X, Office Action mailed Dec. 22, 2023”, w/ English Translation, 8 pgs. [cited by applicant]
“Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma”, A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial Am J Respir Crit Care Med vol. 181., (2010), 9 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Communication Pursuant to Article 94(3) EPC mailed Mar. 20, 2020”, 7 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Communication Pursuant to Article 94(3) EPC mailed Jun. 1, 2018”, 9 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Extended European Search Report mailed Jun. 6, 2016”, 6 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Invitation pursuant to Article 94(3) and Rule 71(1) EPC mailed Oct. 11, 2022”, 4 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Office Action mailed Jun. 12, 2015”, 3 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Response filed Jul. 20, 2020 to Communication Pursuant to Article 94(3) EPC mailed Mar. 20, 2020”, 13 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Response filed Aug. 10, 2022 to Summons to Attend Oral Proceedings mailed Feb. 28, 2022”, 52 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Response filed Oct. 19, 2015 to Office Action mailed Jun. 12, 2015”, 13 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Response filed Dec. 1, 2016 to Extended European Search Report mailed Jun. 6, 2016”, 20 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Summons to Attend Oral Proceedings mailed Jan. 28, 2022”, 10 pgs. [cited by applicant]
“European Application Serial No. 13851462.5, Summons to Attend Oral Proceedings mailed Feb. 28, 2022”, 4 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Communication Pursuant to Article 94(3) EPC mailed Apr. 28, 2022”, 10 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Communication Pursuant to Article 94(3) EPC mailed Apr. 30, 2020”, 8 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Extended European Search Report mailed May 30, 2018”, 15 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Reponse filed Nov. 12, 2018 to Extended European Search Report mailed May 30, 2018”, 17 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Response filed Sep. 2, 2022 to Communication Pursuant to Article 94(3) EPC mailed Apr. 28, 2022”, 116 pgs. [cited by applicant]
“European Application Serial No. 15853911.4, Response filed Oct. 27, 2020 to Communication Pursuant to Article 94(3) EPC mailed Apr. 30, 2020”, 14 pgs. [cited by applicant]
“European Application Serial No. 20832727.0, Extended European Search Report mailed Feb. 28, 2023”, 9 pgs. [cited by applicant]
“European Application Serial No. 20832727.0, Response filed Sep. 26, 2023 to Communication pursuant to Rules 70(2) and 70a(2) EPC mailed Mar. 17, 2023”, 15 pgs. [cited by applicant]
“European Application Serial No. 20832727.0, Response to Communication pursuant to Rules 161 and 162 filed Aug. 19, 2022”, 13 pgs. [cited by applicant]
“European Application Serial No. 23183741.0, Extended European Search Report mailed Jul. 21, 2023”, 14 pgs. [cited by applicant]
“European Application Serial No. 23183741.0, Response filed Feb. 19, 2024 to Extended European Search Report mailed Jul. 21, 2023”, 12 pgs. [cited by applicant]
“International Application Serial No. PCT/US2015/058296, International Preliminary Report on Patentability mailed May 11, 2017”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2015/058296, International Search Report mailed Jan. 21, 2016”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2015/058296, Written Opinion mailed Jan. 21, 2016”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/039605, International Preliminary Report on Patentability mailed Jan. 6, 2022”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/039605, International Search Report mailed Sep. 28, 2020”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/039605, Written Opinion mailed Sep. 28, 2020”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/050087, International Search Report mailed Mar. 1, 2023”, 3 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/050087, Written Opinion mailed Mar. 1, 2023”, 4 pgs. [cited by applicant]
“Japanese Application Serial No. 2015-540733, Office Action mailed Jul. 4, 2017”, w/English Translation, 12 pgs. [cited by applicant]
“Japanese Application Serial No. 2015-540733, Office Action mailed Dec. 29, 2017”, With English Translation, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2015-540733, Response filed Mar. 16, 2018 to Office Action mailed Dec. 29, 2017”, w/ English Claims, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2015-540733, Response filed Oct. 4, 2017 to Office Action mailed Jul. 4, 2017”, w/ English Claims, 19 pgs. [cited by applicant]
“Japanese Application Serial No. 2017-523517, Notification of Reasons for Refusal mailed Jul. 6, 2021”, w/ English Translation, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2017-523517, Notification of Reasons for Rejection mailed Sep. 10, 2019”, w/ English Translation, 13 pgs. [cited by applicant]
“Japanese Application Serial No. 2017-523517, Office Action mailed Jun. 23, 2020”, w/ English translation, 14 pgs. [cited by applicant]
“Japanese Application Serial No. 2017-523517, Response filed Mar. 6, 2020 to Notification of Reasons for Rejection mailed Sep. 10, 2019”, w/English Claims, 14 pgs. [cited by applicant]
“Japanese Application Serial No. 2017-523517, Response filed Oct. 23, 2020 to Office Action mailed Jun. 23, 2020”, w/English Claims, 14 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Examiners Decision of Final Refusal mailed Apr. 7, 2020”, w/ English Translation, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Notification of Reasons for Refusal mailed Jan. 5, 2022”, w/ English Translation, 17 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Notification of Reasons for Refusal mailed Jul. 2, 2019”, W/ English Translation, 16 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Notification of Reasons for Refusal mailed Aug. 17, 2021”, w/ English Translation, 17 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Office Action mailed Nov. 8, 2022”, w/ English Translation, 45 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Response filed Apr. 5, 2022 to Notification of Reasons for Refusal mailed Jan. 5, 2022”, w/ English Claims, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Response filed Oct. 1, 2019 to Notification of Reasons for Refusal mailed Jul. 2, 2019”, w/English Claims, 10 pgs. [cited by applicant]
“Japanese Application Serial No. 2018-153239, Response filed Nov. 16, 2021 to Notification of Reasons for Refusal mailed Aug. 17, 2021”, w/Engilsh Claims, 10 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-134047, Examiners Decision of Final Refusal mailed Jun. 21, 2022”, w/ English translation, 6 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-134047, Notification of Reasons for Refusal mailed Sep. 28, 2021”, w/ English Translation, 16 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-134047, Response filed Mar. 28, 2022 to Notification of Reasons for Refusal mailed Sep. 28, 2021”, w/ English translation, 21 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Notification of Reasons for Refusal mailed Jan. 5, 2022”, w/ English Translation, 8 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Office Action mailed Nov. 22, 2022”, w/o English Translation, 1 pg. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Preliminary Examination Report mailed Jan. 24, 2023”, w/ English Translation, 2 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Response field Dec. 21, 2022 to Office Action mailed Nov. 22, 2022”, w/English Translation, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-178075, Response filed Apr. 5, 2022 to Notification of Reasons for Refusal mailed Jan. 5, 2022”, w English translation, 6 pgs. [cited by applicant]
“Japanese Application Serial No. 202080044525.9, Examiners Decision of Final Refusal mailed Jul. 5, 2022”, w/ English Translation, 8 pgs. [cited by applicant]
“Japanese Application Serial No. 202080044525.9, Response filed Nov. 7, 2022 to Examiners Decision of Final Refusal mailed Jul. 5, 2022”, w/ English Claims, 13 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-169101, Notification of Reasons for Rejection mailed Oct. 31, 2023”, W/ English Translation, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-169101, Response filed Jan. 30, 2024 to Notification of Reasons for Rejection mailed Oct. 31, 2023”, w/ English Claims, 14 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-169101, Voluntary Amendment filed Jun. 19, 2023”, 15 pgs. [cited by applicant]